Skip to content
ChickenStockChickenStock
ResearchPRCT
Procept Biorobotics logo

Procept Biorobotics (PRCT) stock

NASDAQ

$23.79+1.06%(+0.25)

As of the Nov 17, 2026 close (U.S. Eastern)

Events and reference metrics · 1

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 17, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

-11.90x

Net loss — not comparable

P/B

4.19x

P/S

3.92x

Find stocks with P/B ≤ 0.9×

Latest earnings

SEC filings

Jul–Sep 2026(FY2026 Q3)

Revenue increased 18.1% from the same period a year earlier.

Key reported figures come first. Select one to see the same quarter across three years.

See the same quarter across three years →

Filed Nov 4, 2026 · 10-Q · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

10 SEC filings
  • Sharma PoojaChief Strat/Marketing Officer · Nov 6, 2026Open-market sale4,710 shares · $93K
    Avg. price $19.714106,471 shares held after
  • Mack MichaelDirector · Oct 2, 2026Grant or award7,727 shares · $0
    Avg. price $07,727 shares held after
  • Templin Barry LEVP, Chief Technology Officer · Sep 9, 2026Open-market sale373 shares · $8K
    Avg. price $20.95394,826 shares held after
  • Waters KevinEVP, CFO · Sep 9, 2026Open-market sale373 shares · $8K
    Avg. price $20.953180,355 shares held after
  • Nouri AlalehEVP, CLO, CORP. SEC. · Sep 9, 2026Open-market sale297 shares · $6K
    Avg. price $20.953127,737 shares held after
  • Templin Barry LEVP, Chief Technology Officer · Aug 13, 2026Grant or award26,246 shares · $0
    Avg. price $095,199 shares held after
  • Sharma PoojaChief Strat/Marketing Officer · Aug 13, 2026Grant or award23,622 shares · $0
    Avg. price $0111,181 shares held after
  • Waters KevinEVP, CFO · Aug 13, 2026Grant or award29,527 shares · $0
    Avg. price $0180,728 shares held after
  • Nouri AlalehEVP, CLO, CORP. SEC. · Aug 13, 2026Grant or award22,965 shares · $0
    Avg. price $0128,034 shares held after
  • Wood Larry LPresident, CEO · Aug 7, 2026Open-market purchase23,900 shares · $498K
    Avg. price $20.8523,900 shares held after

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Procept Biorobotics (PRCT) stock information

NASDAQ

Procept Biorobotics (PRCT) is listed on NASDAQ. Its market capitalization is about $1.4B. On trailing-twelve-month earnings the P/E ratio is -11.9, and the P/B ratio is 4.19. Return on equity is -35.3%. These figures are computed in-house from official filings and are reference information only.

Procept Biorobotics — frequently asked questions

What is the P/E ratio of Procept Biorobotics (PRCT)?
On a trailing-twelve-month basis, PRCT trades at a P/E ratio of -11.9. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Procept Biorobotics?
PRCT has a market capitalization of about $1.4B. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.